Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

Curcumin may improve blood sugar levels and cholesterol in people with PCOS, but more research is needed.

Women with more body hair tend to have thicker belly fat and more metabolic health issues.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Scalp fungi and sebum differences may affect hair loss in men.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

The treatments for fungal nail infection, hair loss in men, benign nail tumor, and chemotherapy-associated nail bed inflammation are effective and safe.

Premature hair greying may indicate a higher risk of metabolic problems.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Genetics and nutritional deficiencies are key factors in premature graying of hair.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

The PON1 192R gene variant is linked to a higher risk of psoriasis and heart disease in Western Mexico.

Men with early hair loss may have higher insulin resistance and should be checked for related health issues.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

Men with early-onset hair loss have less cardiometabolic benefit from bromocriptine.

Men with early-onset baldness may have a higher risk of heart disease.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Taking 1mg of finasteride daily can mildly improve metabolic health and glucose regulation in men with male pattern baldness.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

Osteopontin levels are higher in people with androgenetic alopecia and are linked to metabolic disorders.

SFRP-4 might be an early indicator of diabetes and hypertension in men with androgenic alopecia.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

Hyperandrogenism in women can cause acne, hair growth, hair loss, irregular periods, and increase the risk of infertility and diabetes.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

Hair loss may increase heart disease risk.